News
Over-the-Counter Birth Control Pills: FDA Considering HRA Pharma’s Opill
Why Over-the-Counter Birth Control? Oral contraceptives have been around since 1960, and their risks and safety profiles have been well-studied throughout the years. According to the Guttmacher Institute, unplanned pregnancies…
Nextstellis®: A new drug update
A new combined oral contraceptive was approved by the FDA (Nextstellis®) in April 2021.1 Nextstellis contains estetrol, an estrogen that can be manufactured from plants and that was originally…
Updated Report on State Policy Efforts to Expand Access to Contraception in Pharmacies
Download free 22-page report describing the current landscape of direct access to contraception in pharmacies, state policy approaches and experiences, as well as implementation.
Levonorgestrel Intrauterine Device for Emergency Contraception
A new research study evaluates levonorgestrel IUD for emergency contraception
Webinar Introduces Pharmacists to New Hormonal Contraceptives
New training program by Birth Control Pharmacist and Provide includes pharmacy best practices to combat stigma and communication guides and online resources to help connect patients with local resources.
Webinar Equips Pharmacists to Provide Contraception Care During COVID-19
New training program by Birth Control Pharmacist and Provide includes pharmacy best practices to combat stigma and communication guides and online resources to help connect patients with local resources.
Reducing Maternal Mortality in the United States through Collaboration
New training program by Birth Control Pharmacist and Provide includes pharmacy best practices to combat stigma and communication guides and online resources to help connect patients with local resources.
Continuing Contraception Care After Trump’s Orders
In light of recent actions over the last two weeks with our new administration, I wanted to provide updates and guidance to my pharmacist peers regarding reproductive health care. On…